Alopecia Clinical Trial
Official title:
"iRestore" Light Therapy Apparatus in the Treatment of Androgenetic Alopecia: A Randomized, Double-blind, Self-comparison, Sham Device-controlled, Multicenter Trial
Current effective therapies of pattern hiar loss are topical minoxidil and oral finasteride.
Finasteride is an inhibitor of type 2 5α-reductase and will cause hypospadias in male infant
if taken or touched by pregnant woman. The effect of minoxidil is still known now but the
dilation of scalp vessel might improve the progression of pattern hair oss. However,
minoxidil is not effective for frontotemporal recession and sometimes cause scalp irritation.
Low-level laser therapy (LLLT) a new therapy to treat alopecia. In 2007, LLLT was approved by
the FDA as a treatment for hair loss. In some small studies, patients had a decrease in the
number of vellus hairs, an increase in the number of terminal hairs, and an increase in shaft
diameter. Up to now, however, no longer, placebo-controlled studies have proved its efficacy
in this application.
According to the mechanism of paradoxical hair growth (PHG), sublethal injury to the hair
follicle could stimulate the hair follicle to enter anagen via the release of factors that
alter angiogenesis, leading to increased blood flow to the dermal papilla. Furthermore, load
inflammation in the papilla nad heat shok response, possibly mediated by HSP27, may play a
role in activation of follicular stem cell.
This study is a randomized, blinded, self-comparison and superior clinical trial design. In
this clinical trial, the investigators try to evaluate the efficacy of low-level laser
therapy in treating pattern hair loss. Pattern hair loss is characterized by increased vellus
hairs and decreased shaft diameter, and these features are improved by LLLT in previous.
This study is A randomized, double-blind, self-comparison, sham device- controlled,
multicenter Trial. Total subjects is 100 and the clinical trial was conducted in National
Taiwan University Hospital and National Taiwan University Hospital-Hsinchu Branch. The study
starts from December 2013 to June 2015 for within 18 months.
The potential subjects will be collected into the clinical study, and have 24 weeks of
treatment. The forth, twelve and twenty-fourth weeks are took as evaluation point. Besides
the photo shooting area, recording the density of hair growth, analyzing of hair growth
number, and the width of hair will be quantified. At the same time, the subject will also
have the safety evaluation to see if there are any reddish or skin disorder(erythema, edema,
dried, skin keratinization) or other systematic symptom. After quantifying the data, the
degree of covered area in target area is seen as primary end point.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04953416 -
Fractional Non-ablative Laser for the Treatment of Hair Loss
|
N/A | |
Completed |
NCT01929330 -
Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers
|
Phase 1 | |
Recruiting |
NCT05213936 -
Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color
|
N/A | |
Completed |
NCT02919735 -
Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)
|
Phase 2 | |
Recruiting |
NCT02591823 -
Hair Fall in Patients on Low Dose Methotrexate
|
N/A | |
Enrolling by invitation |
NCT01651689 -
Hair Counts From Vertical and Horizontal Sections of Scalp Biopsy SPecimens in Thai Population With Alopecia
|
N/A | |
Completed |
NCT01189279 -
Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia
|
Phase 1 | |
Recruiting |
NCT01111981 -
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
|
Phase 4 | |
Terminated |
NCT01385839 -
Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata
|
N/A | |
Active, not recruiting |
NCT03382184 -
Fractional Photothermolysis for Hair Follicle Induction
|
Early Phase 1 | |
Not yet recruiting |
NCT05544448 -
In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases
|
N/A | |
Completed |
NCT03689452 -
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
|
N/A | |
Completed |
NCT06409650 -
To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia
|
Phase 2 | |
Recruiting |
NCT00801086 -
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
|
Phase 2 | |
Completed |
NCT06095739 -
Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002
|
N/A | |
Completed |
NCT05587699 -
The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A
|
Phase 1 | |
Completed |
NCT03351322 -
ENERGI-F701 for Female Hair Loss Treatment
|
Phase 2 | |
Terminated |
NCT02935569 -
Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy
|
N/A | |
Completed |
NCT01590238 -
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
|
Phase 3 | |
Not yet recruiting |
NCT01557491 -
Hair Regrowth After Bicoronal Incision
|
N/A |